Table 3.
Pre- and post-treatment laboratory findings in patients
| Laboratory Parameters | Pre-Treatment | Post-Treatment | p |
|---|---|---|---|
| WBC (m/mm3) | 3500 (2171-12.700) | 5300 (2350-18.200) | 0.168b |
| Absolute Neutrophil Count | 1200 (300-8000) | 1900 (0-16.200) | 0.091b |
| Absolute Lymphocyte Count | 1770 (900-4600) | 2500 (600-4700) | 0.646b |
| Hemoglobin (g/dL) | 9.4±1.6 | 10.1±1.8 | 0.164a |
| Platelet (μL) | 88.000 (10.000-852.000) | 280.000 (57.000-387.000) | 0.062b |
| LDH (U/L) | 329 (200-483) | 281 (177-561) | 0.441b |
| Fibrinogen (mg/dl) | 129 (100-297) | 250 (118-291) | 0.016 b |
| Ferritin (ng/ml) | 1353±673 | 469±278 | <0.001 a |
| Triglycerides (mg/dl) | 375±166 | 255±137 | 0.110a |
| AST (U/L) | 35 (21-479) | 37 (13-241) | 0.350b |
| ALT (U/L) | 39±20 | 48±32 | 0.334a |
| Albumin (g/L) | 34.5±7 | 35.2±7 | 0.589a |
| CRP (mg/L) | 13.6 (1-79) | 5 (1-9) | 0.028 b |
Data were summarized as mean ± standard deviation or median (min-max).
a
paired-samples t-test;
b
Wilcoxon Signed Rank.